PEPTONIC medical AB (publ) (XSAT:PMED)
0.0600
0.00 (0.00%)
At close: Jan 31, 2024
PEPTONIC medical AB Company Description
PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women.
The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopause, vaginal infection, bacterial vaginosis, and amniotic fluid leakage; and gene test for diagnosing vaginal infection.
It also provides VerniVia mousse, a product against bacterial vaginosis. PEPTONIC medical AB (publ) was incorporated in 2009 and is headquartered in Kista, Sweden.
PEPTONIC medical AB (publ)
| Country | Sweden |
| Founded | 2009 |
| Industry | Pharmaceutical Preparations |
| Employees | 2 |
| CEO | Daniel Rudeklint |
Contact Details
Address: Färögatan 33 Kista, 164 53 Sweden | |
| Phone | 46 8 53 02 01 10 |
| Website | peptonicmedical.se |
Stock Details
| Ticker Symbol | PMED |
| Exchange | Spotlight Stock Market |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Rudeklint | Chief Executive Officer |
| Jenni Bjornulfson | Chief Financial Officer |